Search Results - "Visciano, M.L"

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins by Visciano, M.L, Diomede, L, Tagliamonte, M, Tornesello, M.L, Asti, V, Bomsel, M, Buonaguro, F.M, Lopalco, L, Buonaguro, L

“…Abstract Elicitation of a potent and broadly neutralizing antibody response is the main goal of an effective preventive HIV-1 vaccine. It has been shown by us…”
Get full text

Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system by Tagliamonte, M, Visciano, M.L, Tornesello, M.L, De Stradis, A, Buonaguro, F.M, Buonaguro, L

“…Abstract We have previously developed HIV-1 Pr55gag-based virus-like particles (HIV-VLPs) as presentation and delivery model using a transient Baculovirus…”
Get full text

HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line by Tagliamonte, M, Visciano, M.L, Tornesello, M.L, De Stradis, A, Buonaguro, F.M, Buonaguro, L

“…Abstract We have previously described the establishment and characterization of a stably transfected insect cell line for the constitutive and efficient…”
Get full text

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A by Buonaguro, L., Racioppi, L., Tornesello, M.L., Arra, C., Visciano, M.L., Biryahwaho, B., Sempala, S.D.K., Giraldo, G., Buonaguro, F.M.

“…We have recently developed a candidate HIV-1 vaccine based on virus-like particles (VLPs) expressing a gp120 from an Ugandan HIV-1 isolate of the clade A…”
Get full text